Hence, the inactivation of the ATM-CHK2 and ATR-CHK1 pathways efficiently sensitizes the malignant cells, in particular p53-deficient cancer cells, to DNA damage or high levels of replication stress induced by radiotherapy or chemotherapies. Here, TP53 is linked to cancer.